Analyst Ratings for Abeona Therapeutics (ABEO)
Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
---|---|---|---|---|---|---|---|---|
11/30/2021 | Leerink Partners | Mani Foroohar | Downgrade | Market Perform (Outperform) |
N/A (N/A) |
0.65 (3.14) |
383.08% | Details |
11/11/2020 | Cantor Fitzgerald » Updated 8/11/2022 |
Kristen Kluska | Upgrade | Overweight (Neutral) |
22.00 (15.00) |
1.07 (3.14) |
193.46% | Details |